search
Back to results

Use of Implanted Microstimulators for Decreasing Spasticity and Improving Motion Following Spinal Cord Injury

Primary Purpose

Spinal Cord Injury at C5-C7 Level With Incomplete Lesion

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Radio Frequency Microstimulator
Sponsored by
The Alfred E. Mann Foundation for Scientific Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injury at C5-C7 Level With Incomplete Lesion focused on measuring Therapeutic Electric Stimulation, Functional Electric Stimulation, Implantable Stimulator, Muscle Strength, Muscle Spasticity

Eligibility Criteria

55 Years - 55 Years (Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • an incomplete C6 ASIA C (Central Cord) spinal cord injury
  • lower motor function impaired and suffers from significant spasticity (Ashworth scale 4)
  • able to ambulate approximately 10-20 feet with a rolling walker and minimal assistance
  • has sufficient endurance to complete at least two 20-minute therapy sessions per day
  • cognitive abilities are intact

Exclusion Criteria:

  • psychiatric diagnosis
  • medical contraindications
  • history of bleeding disorders
  • allergy to anesthesia
  • acute or progressive disease
  • active implantable device

Sites / Locations

  • Walter Reed Army Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Treatment

Arm Description

Intramuscular Electrical Stimulation

Outcomes

Primary Outcome Measures

Adverse Events
Lower Limb Strength
Lower Limb Spasticity

Secondary Outcome Measures

Mobility

Full Information

First Posted
October 27, 2008
Last Updated
January 19, 2012
Sponsor
The Alfred E. Mann Foundation for Scientific Research
Collaborators
Walter Reed Army Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00781833
Brief Title
Use of Implanted Microstimulators for Decreasing Spasticity and Improving Motion Following Spinal Cord Injury
Official Title
Case Study Testing the Use of Implanted Microstimulators for Decreasing Spasticity and Improving Motion Following Spinal Cord Injury
Study Type
Interventional

2. Study Status

Record Verification Date
January 2012
Overall Recruitment Status
Terminated
Why Stopped
Participation of single subject enrolled was terminated.
Study Start Date
October 2008 (undefined)
Primary Completion Date
June 2010 (Actual)
Study Completion Date
June 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Alfred E. Mann Foundation for Scientific Research
Collaborators
Walter Reed Army Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary aims of this study are to determine the safety of the RFM System (Alfred Mann Foundation, Santa Clarita, CA) in a patient with incomplete SCI and the effect of the RFM system on lower limb strength and spasticity. The secondary aim is to analyze any improvement in the participant's mobility.
Detailed Description
Restoring mobility after spinal cord injury (SCI) is one of the most important goals of rehabilitation. Even for patients with partial lower limb motor function after SCI, many have limited mobility because of significant spasticity. Therapeutic electrical neuromuscular stimulation (TNS) has been used to improve muscle tone and strength and to enable walking and standing in patients with SCI. We propose to use the Radio Frequency Microstimulator (RFM) System, a new and novel implantable TNS system developed by the Alfred E. Mann Foundation, to improve muscle strength and reduce spasticity in a patient with incomplete SCI. The RFM System has several advantages over current TNS systems. The RFM implant devices are small enough (diameter 2.4 mm, length 16.7 mm) to be inserted using an incision approximately 5 mm long and have no lead wires passing through the skin since the microstimulator contains both the anode and cathode. Implanted RFM devices can be placed near multiple motor points and/or nerves and are controlled individually using radio frequency technology. Up to six (6) RFM devices will be inserted, two to three in each lower limb to provide stimulation to a patient's bilateral knee extensors (femoral nerve stimulation) and ankle dorsiflexors (peroneal nerve stimulation) to assess the effects on muscle strength, limb spasticity and patient mobility.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injury at C5-C7 Level With Incomplete Lesion
Keywords
Therapeutic Electric Stimulation, Functional Electric Stimulation, Implantable Stimulator, Muscle Strength, Muscle Spasticity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment
Arm Type
Experimental
Arm Description
Intramuscular Electrical Stimulation
Intervention Type
Device
Intervention Name(s)
Radio Frequency Microstimulator
Intervention Description
Implantable peripheral muscle microstimulator, delivering controlled pulsatile stimulation to femoral nerves for knee extension and peroneal nerves for dorsiflexion.
Primary Outcome Measure Information:
Title
Adverse Events
Time Frame
Throughout
Title
Lower Limb Strength
Time Frame
6, 12, 24 weeks, 12, 24 months
Title
Lower Limb Spasticity
Time Frame
6, 12, 24 weeks, 12, 24 months
Secondary Outcome Measure Information:
Title
Mobility
Time Frame
6, 12, 24 weeks, 12, 24 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: an incomplete C6 ASIA C (Central Cord) spinal cord injury lower motor function impaired and suffers from significant spasticity (Ashworth scale 4) able to ambulate approximately 10-20 feet with a rolling walker and minimal assistance has sufficient endurance to complete at least two 20-minute therapy sessions per day cognitive abilities are intact Exclusion Criteria: psychiatric diagnosis medical contraindications history of bleeding disorders allergy to anesthesia acute or progressive disease active implantable device
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
KEVIN F FITZPATRICK, M.D.
Organizational Affiliation
Walter Reed Army Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Walter Reed Army Medical Center
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20307
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Use of Implanted Microstimulators for Decreasing Spasticity and Improving Motion Following Spinal Cord Injury

We'll reach out to this number within 24 hrs